Meta‐analysis of PD‐(L)1 inhibitor plus chemotherapy versus chemotherapy as first‐line treatment in extensive‐stage small‐cell lung cancer

BACKGROUND: Immunotherapy targeting programmed death 1(PD‐1) and its ligand (PD‐L1) has been successful in extensive‐stage small cell lung cancer (ES‐SCLC). However, first‐line PD‐(L)1 inhibitor combined with chemotherapy (immunochemotherapy) versus chemotherapy has not been well studied. METHODS: R...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiangyue, Lei, Xiao, Zhang, Pei, Du, Lehui, Zhang, Zhibo, Qu, Baolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524002/
https://www.ncbi.nlm.nih.gov/pubmed/37563966
http://dx.doi.org/10.1002/cam4.6433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524002/
https://www.ncbi.nlm.nih.gov/pubmed/37563966
http://dx.doi.org/10.1002/cam4.6433

Ejemplares similares